FR2933692B1 - Nouveaux composes, leur utilisation comme medicaments, et leur procede de preparation - Google Patents

Nouveaux composes, leur utilisation comme medicaments, et leur procede de preparation Download PDF

Info

Publication number
FR2933692B1
FR2933692B1 FR0803940A FR0803940A FR2933692B1 FR 2933692 B1 FR2933692 B1 FR 2933692B1 FR 0803940 A FR0803940 A FR 0803940A FR 0803940 A FR0803940 A FR 0803940A FR 2933692 B1 FR2933692 B1 FR 2933692B1
Authority
FR
France
Prior art keywords
independently represent
group
integers
medicines
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0803940A
Other languages
English (en)
Other versions
FR2933692A1 (fr
Inventor
Raphael Emmanuel Duval
Marion Grare
Maxime Mourer
De Vains Jean Bernard Regnouf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Lorraine
Original Assignee
Universite Henri Poincare Nancy I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Henri Poincare Nancy I filed Critical Universite Henri Poincare Nancy I
Priority to FR0803940A priority Critical patent/FR2933692B1/fr
Priority to CA2730304A priority patent/CA2730304A1/fr
Priority to EP09794039A priority patent/EP2303837A2/fr
Priority to PCT/FR2009/051388 priority patent/WO2010004231A2/fr
Priority to NZ591021A priority patent/NZ591021A/xx
Priority to US13/003,330 priority patent/US8703825B2/en
Publication of FR2933692A1 publication Critical patent/FR2933692A1/fr
Application granted granted Critical
Publication of FR2933692B1 publication Critical patent/FR2933692B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/08—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne de nouveaux composés de formule (I) suivante : g id="ID2933692-3" he="" wi="" file="" img-format="tif"/> > dans laquelle : - n représente un nombre entier compris de 1 à 12, notamment de 1 à 8, - m et m' représentent indépendamment l'un de l'autre des nombres entiers de 0 à 8, - q et q' représentent indépendamment l'un de l'autre des nombres entiers de 0 à 2, - p et p' représentent indépendamment l'un de l'autre des nombres entiers de 0 à 4, - A et A' représentent indépendamment l'un de l'autre un groupe CH2, (cas particulier des amidines) un groupe NH ou un groupe NR", dans lequel R" est un groupe alkyle de 1 à 3 atomes de carbone, linéaire ou ramifié, - B et B' représentent indépendamment l'un de l'autre un atome d'oxygène ou un groupe CH2, - R et R' sont indépendamment l'un de l'autre un halogène, tel que les atomes de chlore, brome, iode ou fluor, ou un groupe alkyle de 1 à 3 atomes de carbone, linéaire ou ramifié, leur utilisation comme médicaments et leur procédé de préparation.
FR0803940A 2008-07-10 2008-07-10 Nouveaux composes, leur utilisation comme medicaments, et leur procede de preparation Active FR2933692B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0803940A FR2933692B1 (fr) 2008-07-10 2008-07-10 Nouveaux composes, leur utilisation comme medicaments, et leur procede de preparation
CA2730304A CA2730304A1 (fr) 2008-07-10 2009-07-10 Nouveaux composes, leur utilisation comme medicaments, et leur procede de preparation
EP09794039A EP2303837A2 (fr) 2008-07-10 2009-07-10 Nouveaux composes, leur utilisation comme medicaments, et leur procede de preparation
PCT/FR2009/051388 WO2010004231A2 (fr) 2008-07-10 2009-07-10 Nouveaux composes, leur utilisation comme medicaments, et leur procede de preparation
NZ591021A NZ591021A (en) 2008-07-10 2009-07-10 Phenoxyalkanes or phenylalkanes with guanidine or imine groups, and their use in treating various infections
US13/003,330 US8703825B2 (en) 2008-07-10 2009-07-10 Compounds, use thereof as medicaments, and method of preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0803940A FR2933692B1 (fr) 2008-07-10 2008-07-10 Nouveaux composes, leur utilisation comme medicaments, et leur procede de preparation

Publications (2)

Publication Number Publication Date
FR2933692A1 FR2933692A1 (fr) 2010-01-15
FR2933692B1 true FR2933692B1 (fr) 2022-12-02

Family

ID=40289121

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0803940A Active FR2933692B1 (fr) 2008-07-10 2008-07-10 Nouveaux composes, leur utilisation comme medicaments, et leur procede de preparation

Country Status (6)

Country Link
US (1) US8703825B2 (fr)
EP (1) EP2303837A2 (fr)
CA (1) CA2730304A1 (fr)
FR (1) FR2933692B1 (fr)
NZ (1) NZ591021A (fr)
WO (1) WO2010004231A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9108972B2 (en) * 2011-03-03 2015-08-18 Cadila Healthcare Limited Salts of DPP-IV inhibitor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB938042A (en) * 1961-03-30 1963-09-25 Wellcome Found Phenoxyalkanes
US3896235A (en) * 1970-09-01 1975-07-22 Burroughs Wellcome Co Anthelmintic ethers and composition thereof
DE2658329C2 (de) * 1976-12-23 1983-01-13 Hoechst Ag, 6000 Frankfurt Nitroaminäther, Verfahren zu ihrer Herstellung und ihre Verwendung als Disazoverbindungen
BR0212078A (pt) * 2001-08-31 2004-09-28 Neurochem Int Ltd Método de tratar ou prevenir uma doença relacionada com amilóide em um paciente, composição farmacêutica, composto quìmico, e, uso de um composto
WO2003103598A2 (fr) * 2002-06-07 2003-12-18 University Of North Carolina At Chapel Hill Derives d'amidine pour le traitement des amyloses

Also Published As

Publication number Publication date
US8703825B2 (en) 2014-04-22
WO2010004231A3 (fr) 2010-03-04
NZ591021A (en) 2012-11-30
US20110184070A1 (en) 2011-07-28
WO2010004231A2 (fr) 2010-01-14
EP2303837A2 (fr) 2011-04-06
CA2730304A1 (fr) 2010-01-14
FR2933692A1 (fr) 2010-01-15

Similar Documents

Publication Publication Date Title
TNSN07393A1 (fr) Nouveaux ligands du recepteur h3 de l'histamine et leurs applications therapeutiques
MA30695B1 (fr) Derives de n-(amino-heteroaryl)-1h-indole -2-carboxamides, leur preparation et leur application en therapeutique.
MA30226B1 (fr) Agents cytotoxiques comprenant de nouveaux derives de tomaymycine et leur utilisation therapeutique.
TW200519088A (en) Aryl or heteroaryl amide compounds
MA34450B1 (fr) Dérivés de l'imidazopyridine, procédé pour leur préparation, et leur utilisation thérapeutique
MA31703B1 (fr) Dérivés pyridiniques utilisés comme modulateurs du récepteur s1p1/edg1
CA2797921A1 (fr) Nouveaux composes anticancereux contenant de l'iridium/rhodium
MA32087B1 (fr) Derives d'indole 2-carboxamides et d'azaindole 2-carboxamides substitues par un groupe silanyle, leur preparation et leur application en therapeutique
MA32090B1 (fr) Dérivés de carboxamides azabicycliques, leur préparation et leur application en thérapeutique
CA2662848C (fr) Derives de 2-aryl-6-phenyl-imidazo[1,2-.alpha.]pyridines, leur preparation et leur application en therapeutique
MA34451B1 (fr) Dérivés de l'indolizine, procédé pour leur préparation, et leur utilisation thérapeutique
PT1408984E (pt) Compostos organofosforosos para activar células t gama/delta
CA2397636A1 (fr) Derives amines de dihydro-1,3,5-triazine et leurs applications en therapeutique
EA200870321A1 (ru) Способ получения 4-оксохинолинового соединения
FR2854633A1 (fr) Derives de piperidinyl-et piperazinyl-alkylcarbamates, leur preparation et leur application en therapeutique
MA30609B1 (fr) Imidazolidine-2,4-diones arylaminoaryl-alkyl-substituees, leur procede de synthese, les medicaments comprenant ces composes, et leurs applications.
MA29698B1 (fr) Dérivés de n-(hétéroaryl)-1-hétéroarylalkyl-1h-indole-2-carboxamides, leur préparation et leur application en thérapeutique.
HUP0400926A2 (hu) Lipidszintcsökkentő új bifenilkarboxamidok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
MA41494B1 (fr) Composés benzoxaborole substitués en position 4 et utilisations associées
WO2007125398A3 (fr) Sulfonamides
MA31674B1 (fr) Dérivés de 7 -alkynyl-1,8-naphthyridones, leur préparation et leur application en thérapeutique
EA200000431A2 (ru) Новые замещенные димерные соединения, способ их получения и фармацевтические композиции, содержащие их
FR3037953B1 (fr) Procede de synthese de molecules portant une fonction oxyde de nitrile
FR2933692B1 (fr) Nouveaux composes, leur utilisation comme medicaments, et leur procede de preparation
MA30222B1 (fr) Nouveaux composes pyridinylaminoalkylene-et pyridinyloxyalkylene-cyclopropanamines polysubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Legal Events

Date Code Title Description
TP Transmission of property

Owner name: UNIVERSITE DE LORRAINE, FR

Effective date: 20130103

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16